RHOA and metabolic disease: Considering recent advances in understanding RhoA/ROCK signaling in regulating metabolic functions, promoting brown adipogenesis and browning process of WAT by ROCK inhibition, particularly ROCK2 inhibition, have emerged as promising strategies to treat obesity and its related metabolic disorders.